138 related articles for article (PubMed ID: 32299624)
1. [Off-label drugs in childhood psoriasis].
Mahé E; Corgibet F; Maccari F; Hadj-Rabia S; Phan C; Ruer-Mulard M; Boralévi F; Barbarot S; Bursztejn AC; Lahfa M; Severino-Freire M; Aubin F; Barthélémy H; Amy de la Bretêque M; Beauchet A; ; ; ;
Ann Dermatol Venereol; 2020; 147(6-7):429-438. PubMed ID: 32299624
[TBL] [Abstract][Full Text] [Related]
2. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
3. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
4. [Justification of off-label antibiotics uses in hospitalized children].
Berthod C; Kassaï B; Boussageon R; ; Adelaide L; Jacquet-Lagrèze M; Lajoinie A
Therapie; 2017 Dec; 72(6):649-658. PubMed ID: 28647107
[TBL] [Abstract][Full Text] [Related]
5. Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies.
Feka A; Di Paolo ER; Pauchard JY; Mariguesa A; Gehri M; Sadeghipour F
Swiss Med Wkly; 2022 Jan; 152():w30124. PubMed ID: 35147399
[TBL] [Abstract][Full Text] [Related]
6. Off-label drug prescribing in a Portuguese paediatric emergency unit.
Ribeiro M; Jorge A; Macedo AF
Int J Clin Pharm; 2013 Feb; 35(1):30-6. PubMed ID: 23054136
[TBL] [Abstract][Full Text] [Related]
7. [Off-label use of recombinant factor VII (rFVIIa) in teaching hospitals in Paris in 2010].
Bardon J; Fink J; de Montblanc J; Bergmann JF; Sarrut B; Benhamou D
Ann Fr Anesth Reanim; 2013 Oct; 32(10):659-64. PubMed ID: 23953834
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Children with Psoriasis from the BiPe Cohort: Are Patients Using Biotherapies in Real Life Eligible for Phase III Clinical Studies?
Phan C; Beauchet A; Burztejn AC; Severino-Freire M; Mazereeuw-Hautier J; Barbarot S; Girard C; Lasek A; Reguiai Z; Abasq C; Sassolas B; Droitcourt C; Perrussel M; Hadj-Rabia S; Mallet S; Phan A; Lacour JP; Bourrat E; Aubin F; Mahé E;
Paediatr Drugs; 2019 Jun; 21(3):169-175. PubMed ID: 31155692
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment with corticosteroids in psoriasis--health care provision far beyond the S3-guidelines.
Augustin M; Schäfer I; Reich K; Glaeske G; Radtke M
J Dtsch Dermatol Ges; 2011 Oct; 9(10):833-8. PubMed ID: 21627773
[TBL] [Abstract][Full Text] [Related]
10. Off-label and unlicensed paediatric prescribing in a community setting: a prospective longitudinal cohort study in Malta.
Ellul IC; Grech V
Paediatr Int Child Health; 2014 Feb; 34(1):12-8. PubMed ID: 24502853
[TBL] [Abstract][Full Text] [Related]
11. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on the pharmacological management of psoriasis in pediatric and adolescent patients.
Mahé E; Amy De La Bretêque M; Phan C
Expert Rev Clin Pharmacol; 2021 Jul; 14(7):807-819. PubMed ID: 33784929
[TBL] [Abstract][Full Text] [Related]
13. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
[TBL] [Abstract][Full Text] [Related]
14. [Drug prescriptions study in the outpatient setting: assessment of off-label uses in children].
Blanco-Reina E; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Bellido-Estévez I
Aten Primaria; 2015; 47(6):344-50. PubMed ID: 25443768
[TBL] [Abstract][Full Text] [Related]
15. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
[TBL] [Abstract][Full Text] [Related]
16. Off-label paediatric drug use in an Indonesian community setting.
Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
[TBL] [Abstract][Full Text] [Related]
17. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
18. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
[TBL] [Abstract][Full Text] [Related]
19. Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry.
Braüner JV; Johansen LM; Roesbjerg T; Pagsberg AK
J Clin Psychopharmacol; 2016 Oct; 36(5):500-7. PubMed ID: 27529772
[TBL] [Abstract][Full Text] [Related]
20. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
